MedPath

The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website
http://www.hopkinsmedicine.org/kimmel_cancer_center

Low Dose Radiation Therapy for Glioblastoma Multiforme

Phase 2
Completed
Conditions
High Grade Glioma
Interventions
Radiation: Low Dose Fractionated Radiation Therapy (LDFRT)
First Posted Date
2011-11-08
Last Posted Date
2023-07-03
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
31
Registration Number
NCT01466686
Locations
🇺🇸

Sibley Memorial Hospital, Washington, District of Columbia, United States

🇺🇸

Suburban Hospital, Bethesda, Maryland, United States

🇺🇸

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer

Phase 2
Completed
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2011-10-25
Last Posted Date
2021-05-19
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
44
Registration Number
NCT01459614
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Decision Support for Women With Breast Cancer

Not Applicable
Terminated
Conditions
Breast Neoplasms
Interventions
Behavioral: Decision control preference scale
First Posted Date
2011-10-06
Last Posted Date
2014-04-09
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
14
Registration Number
NCT01447771
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Endothelial Function, Arterial Stiffness and Components

Completed
Conditions
Acute Lymphoblastic Leukemia
First Posted Date
2011-09-23
Last Posted Date
2013-04-17
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
32
Registration Number
NCT01439217
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

🇺🇸

Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

Phase 1
Completed
Conditions
Solid Tumors
Thyroid Cancer
Soft-tissue Sarcoma
Cholangiocarcinoma
Interventions
First Posted Date
2011-09-22
Last Posted Date
2018-08-29
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
89
Registration Number
NCT01438554
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

Phase 1
Completed
Conditions
Melanoma
Interventions
Biological: melanoma GVAX
First Posted Date
2011-09-16
Last Posted Date
2016-05-24
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
21
Registration Number
NCT01435499
Locations
🇺🇸

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Phase 1
Terminated
Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
Drug: LDE225-600mg
Drug: LDE225-400mg
Drug: LDE225-800mg
First Posted Date
2011-09-12
Last Posted Date
2020-01-22
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
23
Registration Number
NCT01431794
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer

Phase 1
Completed
Conditions
Prostate Cancer
Interventions
First Posted Date
2011-08-16
Last Posted Date
2019-01-17
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
5
Registration Number
NCT01417182
Locations
🇺🇸

Johns Hopkins Outpatient Center, Baltimore, Maryland, United States

Bone Marrow Transplant Trial for Patients With Refractory Severe Aplastic Anemia

Phase 2
Terminated
Conditions
Severe Aplastic Anemia
First Posted Date
2011-06-28
Last Posted Date
2016-10-13
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
4
Registration Number
NCT01383434
Locations
🇺🇸

The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma

Phase 2
Terminated
Conditions
Multiple Myeloma
Interventions
First Posted Date
2011-06-15
Last Posted Date
2018-12-10
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
14
Registration Number
NCT01374217
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath